Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Instituto de Investigación en Oncología Radioterápica (IROR) is a specialized Spanish research organization dedicated to the advancement of radiation oncology and clinical cancer research. Closely integrated with the GenesisCare network in Spain, the institute focuses on optimizing radiotherapy protocols and evaluating innovative treatment technologies such as SBRT and brachytherapy. IROR conducts numerous clinical trials aimed at improving patient outcomes and reducing toxicity across various solid tumors, including prostate, breast, and lung cancers. Beyond clinical research, the institute is heavily involved in academic training, scientific publication, and the development of evidence-based clinical guidelines. It serves as a critical bridge between technological innovation in medical physics and daily clinical practice in oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto de Investigación en Oncología Radioterápica.